2024-516907-18-00SuspendedPhase 1
A Study to Learn About How Different Formulations of the Medicine Called Mevrometostat are Taken up Into the Blood in Healthy Adult Participants
Source: EU CTIS (euclinicaltrials.eu) · Last updated 19 Nov 2024
- Status (registry)
- Suspended
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (estimated)
- First submitted
- 16 Oct 2024
- Start date
- 20 Nov 2024
- Lead sponsor
- Pfizer Inc.
- EU CT number
- 2024-516907-18-00
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pfizer Clinical Research Unit | Brussels | Belgium | Suspended |
This page is information, not medical advice. Discuss any trial with your doctor.